Difluprednate
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications
Evaluating the Efficacy and Safety of Topical Difluprednate in Patients with Chronic Central Serous Chorioretinopathy.
Journal: Retina (Philadelphia, Pa.)
Published: July 30, 2026
Zebrafish Functional Screening of FDA-Approved Drugs for Autosomal Dominant Retinitis Pigmentosa Caused by RHODOPSIN Q344X Mutation.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Preoperative Intravitreal Viscoelastic Injection (PIVOT) for Surgical Optimization in Rhegmatogenous Retinal Detachment With Choroidal Detachment.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: April 22, 2026
Treatment of Central Serous Chorioretinopathy With Topical Difluprednate: A Literature Review.
Journal: Cureus
Published: March 15, 2026
Drugs Associated with Pediatric Cataracts: A Real-World Pharmacovigilance Study.
Journal: Children (Basel, Switzerland)
Published: January 07, 2026
Time Required for Topical Difluprednate to Suppress the Intradermal Histamine-Induced Vascular Reaction in Dogs.
Journal: Veterinary dermatology
Published: December 07, 2025
Acral lentiginous melanoma metastases to the vitreous masquerading as uveitis: A case report.
Journal: American journal of ophthalmology case reports
Published: December 01, 2025
Steroids and Cross-Linking for Ulcer Treatment: The SCUT II Randomized Clinical Trial.
Journal: JAMA ophthalmology
Published: July 24, 2025
A Retrospective Data Analysis of Patients Treated with Difluprednate and Bromfenac for Cystoid Macular Edema After Uveitis or Cataract Surgery.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: April 09, 2025
Uveitis associated with immunotherapy and its response to monotherapy with difluprednate: A case report.
Journal: Archivos de la Sociedad Espanola de Oftalmologia
Published: March 15, 2025
Last Updated: 09/26/2026